SI-BONE, Inc. Reports Third Quarter 2026 Financial Results

SI-BONE reported third-quarter 2026 revenue of $55.7 million, above the $55.3 million FactSet consensus estimate. Net loss narrowed to $3.6 million, or $0.08 per diluted share, from $4.6 million, or $0.11 per share, a year earlier, while adjusted EBITDA increased to $3.0 million from $2.3 million. The company reaffirmed its 2026 worldwide revenue and gross margin guidance and lowered its expected operating expense growth rate to 10.5%. CEO Laura Francis cited procedure-volume growth and physician engagement as drivers.